NCT00014495View on ClinicalTrials.gov

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Interventions
BIOLOGICAL

filgrastim

DRUG

cytarabine

RADIATION

bismuth Bi213 monoclonal antibody M195

Trial Locations (1)

10021

Memorial Sloan - Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00014495 - Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer | Biotech Hunter | Biotech Hunter